Tissue engineering seeds living cells onto a porous
biocompatible scaffold; cells attach, proliferate and secrete
extracellular matrix, gradually filling the scaffold's pores —
"confluence" — before it can be implanted or matured further in
a bioreactor.
Porosity is a trade-off: a more porous scaffold has
wider, better-connected channels so nutrients and oxygen diffuse
deeper into the construct and cells migrate more freely — but
the thinner, sparser struts leave it mechanically weaker and
more prone to collapsing under load. Growth factors are
signalling proteins (e.g. VEGF, TGF-β, FGF) added to the culture
medium that bind cell-surface receptors and accelerate
proliferation and matrix production without changing how many
cells were seeded initially.
- Seeding density — how many cells are attached to the scaffold at the start.
- Growth-factor concentration — how quickly seeded cells proliferate over time.
- Scaffold porosity — how open/sparse the lattice struts are, trading strength for diffusion.
This mirrors real regenerative-medicine work such as growing
cartilage patches for joint repair or lab-grown skin grafts for
burn victims, where scaffold pore size and growth-factor dosing
are tuned to balance strength, nutrient supply and how fast the
tissue matures.